Company / Shareholders' Equity
Silo Pharma, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$6.2M
FY2025
5-year range
$407.4K / $10.3M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $10M to $6M over the past 2 years.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +72.2%.
Declined from $10M to $6M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +72.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +72.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 0.0% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.2M | +0.0% |
| FY2024 | $6.2M | -40.3% |
| FY2023 | $10.3M | +2438.0% |
| FY2020 | $407.4K | +0.0% |
| FY2019 | $407.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026